| Authors: |
Feng Y; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30033., Daley-Bauer LP; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30033., Roback L; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30033., Guo H; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30033., Koehler HS; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30033., Potempa M; Department of Microbiology and Immunology, University of California, San Francisco, CA 94143.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA 94143., Lanier LL; Department of Microbiology and Immunology, University of California, San Francisco, CA 94143; lewis.lanier@ucsf.edu mocarski@emory.edu.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA 94143., Mocarski ES; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30033; lewis.lanier@ucsf.edu mocarski@emory.edu. |
